A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC

Clinical trial NCT04844983 · COMPLETED

Trial details

NCT number: NCT04844983
Sponsor: Sirnaomics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma in Situ

Start date: 2021-05-18
Primary completion: 2022-08-24
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.